Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

被引:287
|
作者
Reid, Brian J. [1 ,2 ,3 ,4 ]
Li, Xiaohong [1 ]
Galipeau, Patricia C. [1 ,2 ]
Vaughan, Thomas L. [1 ,5 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
[3] Univ Washington, Dept Med, Seattle, WA 98109 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA
[5] Univ Washington, Dept Epidemiol, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HIGH-GRADE DYSPLASIA; ENDOSCOPIC BIOPSY SURVEILLANCE; HELICOBACTER-PYLORI INFECTION; FLOW CYTOMETRIC ABNORMALITIES; LEUKOCYTE TELOMERE LENGTH; GENE-EXPRESSION PROFILES; SQUAMOUS-CELL CARCINOMA;
D O I
10.1038/nrc2773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of this disease is on the rise in Asian populations in which it has been rare. Much has been learned of host and environmental risk factors that affect the incidence of oesophageal adenocarcinoma, and data indicate that patients with Barrett's oesophagus rarely develop oesophageal adenocarcinoma. Given that 95% of oesophageal adenocarcinomas arise in individuals without a prior diagnosis of Barrett's oesophagus, what strategies can be used to reduce late diagnosis of oesophageal adenocarcinoma?
引用
收藏
页码:87 / 101
页数:15
相关论文
共 50 条
  • [1] Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
    Brian J. Reid
    Xiaohong Li
    Patricia C. Galipeau
    Thomas L. Vaughan
    [J]. Nature Reviews Cancer, 2010, 10 : 87 - 101
  • [2] Oesophageal adenocarcinoma and Barrett's oesophagus
    Das, Manjulika
    [J]. LANCET ONCOLOGY, 2016, 17 (12): : E524 - E524
  • [3] Epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma
    Perez, Nancy
    Taylor, William
    [J]. MEDICAL STUDIES-STUDIA MEDYCZNE, 2019, 35 (01) : 61 - 68
  • [4] Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
    Gregson, Eleanor M.
    Bornschein, Jan
    Fitzgerald, Rebecca C.
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (04) : 403 - 410
  • [5] Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma
    Fitzgerald, R. C.
    [J]. GUT, 2006, 55 (12) : 1810 - 1818
  • [6] Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus
    Holmberg, Dag
    Ness-Jensen, Eivind
    Mattsson, Fredrik
    El-Serag, Hashem B.
    Lagergren, Jesper
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 75 : 41 - 46
  • [7] Genetic progression of Barrett’s oesophagus to oesophageal adenocarcinoma
    Eleanor M Gregson
    Jan Bornschein
    Rebecca C Fitzgerald
    [J]. British Journal of Cancer, 2016, 115 : 403 - 410
  • [8] MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma
    Wijnhoven, B. P. L.
    Hussey, D. J.
    Watson, D. I.
    Tsykin, A.
    Smith, C. M.
    Michael, M. Z.
    [J]. BRITISH JOURNAL OF SURGERY, 2010, 97 (06) : 853 - 861
  • [9] A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma
    Schneider, Jennifer L.
    Corley, Douglas A.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2015, 29 (01) : 29 - 39
  • [10] THE CLONAL PROGRESSION OF BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA
    Khan, S.
    Zeki, S.
    Mitchell, I.
    Harrison, R.
    Dunn, L.
    Leedham, S.
    Barr, H.
    Shepherd, N.
    Graham, T.
    Wright, N.
    McDonald, S.
    [J]. GUT, 2012, 61 : A36 - A37